Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.95
-1.01 (-14.46%)
At close: Mar 28, 2025, 4:00 PM
6.00
+0.05 (0.91%)
After-hours: Mar 28, 2025, 7:46 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $280.81 million as of March 28, 2025. Its market cap has increased by 518.48% in one year.
Market Cap
280.81M
Enterprise Value
191.63M
1-Year Change
518.48%
Ranking
Category
Stock Price
$5.95
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $280.81M, an increase of 26.27%. That is a compound annual growth rate of 6.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 280.81M | -23.83% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |